This NDC is on FDA's drug shortage list (posted Mar 10, 2023)
Product Information
KLONOPIN 1 MG TABLET is a brand product labeled by H2-Pharma LLC, priced at $3.0537 per EA under NDC 61269061010. Its NADAC has been published 243 times since Feb 9, 2022.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Clonazepam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/1
Manufacturer
H2-Pharma LLCNDC
61269061010
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLONAZEPAMApproval Type
New Drug (NDA)
FDA Application
NDA017533FDA Approved
Before 1982
TE Code
AB
On Market Since
6/2/1975
Pharmacological Classes
Price Statistics
The NADAC for KLONOPIN 1 MG TABLET has been published 243 times since Feb 9, 2022, and over the history we have for it it has risen 9.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.0537 per EA |
|---|---|
| All-time high | $3.0637 (Aug 12, 2026) |
| All-time low | $2.7848 (Mar 22, 2023) |
| 52-week high | $3.0637 |
| 52-week low | $2.7867 |
| Median price | $2.7905 |
| Average price | $2.8209 |
| Largest weekly change | +9.9% (Apr 8, 2026) |
| Weeks tracked | 243 |
| Tracking since | Feb 9, 2022 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
H2-Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clonazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KLONOPIN 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for KLONOPIN 1 MG TABLET, manufactured by H2-Pharma LLC, is $3.0537 per EA (NDC 61269061010), effective Sep 30, 2026.
How has the price of KLONOPIN 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for KLONOPIN 1 MG TABLET has risen 9.5%. It has been tracked across 243 weekly CMS publications since Feb 9, 2022.
What are the highest and lowest recorded NADAC prices for KLONOPIN 1 MG TABLET?
Since Feb 9, 2022, the NADAC for KLONOPIN 1 MG TABLET has ranged from a low of $2.7848 (Mar 22, 2023) to a high of $3.0637 (Aug 12, 2026), with a median of $2.7905 per EA.
Are there cheaper alternatives to KLONOPIN 1 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLONAZEPAM 1 MG TABLET, is $0.0244 per EA — about 99% below KLONOPIN 1 MG TABLET.
Who manufactures KLONOPIN 1 MG TABLET?
KLONOPIN 1 MG TABLET (NDC 61269061010) is labeled by H2-Pharma LLC, and CMS classifies it as a brand product.
Is KLONOPIN 1 MG TABLET in shortage?
Yes — NDC 61269061010 is currently listed in FDA's drug shortage database (posted Mar 10, 2023).